再切除在肝癌复发治疗中的作用和地位  

Role of re-resection in treatment of recurrent hepatocellular carcinoma

作　　者：武金才[1] 陆才德[2] 彭淑牖[2] 戴德坚[2] 

机构地区：[1]衢州市人民医院肝胆外科,浙江省324000 [2]浙江大学医学院附属二院

出　　处：《中华肝胆外科杂志》2004年第1期14-16,共3页Chinese Journal of Hepatobiliary Surgery

摘　　要：目的　探讨再切除在肝癌术后复发治疗中的价值。方法　回顾性分析 1988～ 1999年30例肝癌复发再手术切除的随访资料。结果　对 30例肝癌术后复发病人共行 33例次手术 ,首次手术后 1,2 ,3,5年总生存率分别为 93 3,73 3,5 6 7,36 7%。第一次再手术后 1,3,5年生存率分别为6 3 3,2 3 3,13 3%。肺转移切除后 1,3,5年生存率分别为 71 4 ,4 2 9,2 8 6 %。结论　肝癌术后复发行再切除能显著提高病人远期生存率 ,是目前肝癌术后复发的首选治疗方案。Objective To investigate the role of re-resection in treatment of recurrent hepatocellular carcinoma (HCC). Methods The follow-up data of 30 cases of recurrent HCC receiving re-resection in our hospital from 1988 to 1999 were retrospectively analyzed. Results The repeated resection was performed for 33 times in 30 cases of recurrent HCC. The 1-, 2-, 3- and 5-year survival rates in the patients after the first operation were 93.3%, 73.3%, 56.7% and 36.7%, respectively. The 1-, 3- and 5-year survival rates were 63.3%, 23.3% and 13.3%, respectively, after the first re-resection and 71.4%, 42.9% and 28.6%, respectively, after resection of pulmonary metastatic lesions. Conclusions Re-resection of recurrent HCC can markedly prolong the survival of patients. Thus it is of first choice for treatment of recurrent HCC after the first operation.

关 键 词：肝癌 再切除 术后复发 生存率 癌复发 治疗中 病人 远期 

分 类 号：R735.7[医药卫生—肿瘤]